Performance of bioresorbarble scaffold in primary percutaneous intervention of ST elevation myocardial infarct

Withdrawn

• Conditions: coronary artery disase. myocardial infarction; 10011082

• Registration Number: NL-OMON43286
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

1) History of chest pain < 12 hrs
2) ST elevation of * 2 mm in *2 contiguous precordial leads (V1-V6), and/or * 1 mm in * 2 contiguous standard leads (I, II, III, aVf, aVr,aVl).
3) Clinical decision to treat with primary PCI
4) > 18 years
5) Oral informed consent

Exclusion Criteria

1) Contraindications to long term DAPT
2) Known kidney failure with GFR < 45
3) Cardiac arrest or severe cardiogenic shock (Persistent BP <90 mmHg, despite adequate treatment)
4) Other severe illness with life expectancy of less than 12 months (eg. malignancy, severe malnutrition, degenerative disease);Procedural contra-indications:
1) Heavy calcification, tortuous vessel or large side branch (> 2,5 mm) at culprit lesion.
2) TIMI 0-1 flow after aspiration
3) Unable to advance thrombus aspiration catheter

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Minimum flow area by OCT after 12 months </p><br>